101 related articles for article (PubMed ID: 8651582)
21. Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells.
Clarke R; Currier S; Kaplan O; Lovelace E; Boulay V; Gottesman MM; Dickson RB
J Natl Cancer Inst; 1992 Oct; 84(19):1506-12. PubMed ID: 1359153
[TBL] [Abstract][Full Text] [Related]
22. Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.
Bayliss J; Hilger A; Vishnu P; Diehl K; El-Ashry D
Clin Cancer Res; 2007 Dec; 13(23):7029-36. PubMed ID: 18056179
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.
Klapper LN; Kirschbaum MH; Sela M; Yarden Y
Adv Cancer Res; 2000; 77():25-79. PubMed ID: 10549355
[TBL] [Abstract][Full Text] [Related]
24. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.
Fernandez-Pol JA
Crit Rev Oncog; 1991; 2(2):173-85. PubMed ID: 1677274
[TBL] [Abstract][Full Text] [Related]
25. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence.
Ignatoski KM; Lapointe AJ; Radany EH; Ethier SP
Endocrinology; 1999 Aug; 140(8):3615-22. PubMed ID: 10433219
[TBL] [Abstract][Full Text] [Related]
26. Altered gene expression in drug-resistant human breast cancer cells.
Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation.
Giani C; Casalini P; Pupa SM; De Vecchi R; Ardini E; Colnaghi MI; Giordano A; Ménard S
Oncogene; 1998 Jul; 17(4):425-32. PubMed ID: 9696035
[TBL] [Abstract][Full Text] [Related]
28. erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
Colomer R; Lupu R; Bacus SS; Gelmann EP
Br J Cancer; 1994 Nov; 70(5):819-25. PubMed ID: 7947086
[TBL] [Abstract][Full Text] [Related]
29. ErbB receptors and their ligands in the breast.
Zahnow CA
Expert Rev Mol Med; 2006 Sep; 8(23):1-21. PubMed ID: 16984691
[TBL] [Abstract][Full Text] [Related]
30. NDF/heregulins stimulate expression of the erbB-2 tyrosine kinase growth factor receptor gene in human breast cancer cells.
Maggiora P; De Bortoli M
Ann N Y Acad Sci; 1996 Apr; 784():443-7. PubMed ID: 8651595
[No Abstract] [Full Text] [Related]
31. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
[TBL] [Abstract][Full Text] [Related]
32. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.
Ito I; Yoshimoto M; Iwase T; Watanabe S; Katagiri T; Harada Y; Kasumi F; Yasuda S; Mitomi T; Emi M
Br J Cancer; 1995 Mar; 71(3):438-41. PubMed ID: 7880720
[TBL] [Abstract][Full Text] [Related]
33. Neuregulin-regulated gene expression in mammary carcinoma cells.
Amin DN; Tuck D; Stern DF
Exp Cell Res; 2005 Sep; 309(1):12-23. PubMed ID: 15963498
[TBL] [Abstract][Full Text] [Related]
34. Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance.
Lupu R; Cardillo M; Harris L; Hijazi M; Rosenberg K
Semin Cancer Biol; 1995 Jun; 6(3):135-45. PubMed ID: 7495981
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
[TBL] [Abstract][Full Text] [Related]
36. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
Read LD; Keith D; Slamon DJ; Katzenellenbogen BS
Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345
[TBL] [Abstract][Full Text] [Related]
37. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
[TBL] [Abstract][Full Text] [Related]
38. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
39. A new understanding of the hormonal regulation of endocrine dependent cancer.
Waxman J
Br Med Bull; 1991 Jan; 47(1):197-208. PubMed ID: 1650622
[TBL] [Abstract][Full Text] [Related]
40. New insights into anti-HER-2 receptor monoclonal antibody research.
Kumar R; Mandal M; Vadlamudi R
Semin Oncol; 2000 Dec; 27(6 Suppl 11):84-91; discussion 92-100. PubMed ID: 11236033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
